JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Nasopharyngeal carcinoma survival by histology in endemic and non-endemic areas

  • 0Department of Radiation Oncology, Xiamen Cancer Quality Control Center, Xiamen Cancer Center, Xiamen Key Laboratory of Radiation Oncology, the First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, People's Republic of China.
Annals of Medicine +

|

November 12, 2024

|

November 12, 2024

View abstract on PubMed

Summary

This summary is machine-generated.

Histological subtypes significantly impact nasopharyngeal carcinoma (NPC) outcomes. WHO II subtype NPC patients showed worse survival rates compared to WHO III, indicating histology is a key prognostic factor.

Area Of Science

  • Oncology
  • Pathology
  • Epidemiology

Background

  • Nasopharyngeal carcinoma (NPC) is a significant health concern.
  • Histological classification is crucial for understanding NPC.
  • Prognostic implications of NPC histology require further investigation.

Purpose Of The Study

  • To investigate the prognostic implications of histological subtypes in nasopharyngeal carcinoma (NPC).
  • To compare outcomes between WHO II and WHO III NPC subtypes.
  • To analyze NPC prognosis using Chinese and US population data.

Main Methods

  • Retrospective analysis of two independent cohorts: Xiamen (XM)-NPC (726 patients) and Surveillance, Epidemiology, and End Results (SEER)-NPC (1334 patients).
  • Inclusion criteria: patients diagnosed with WHO II and III NPC subtypes.
  • Statistical analysis including survival rates (locoregional relapse-free, distant metastasis-free, disease-free, NPC-specific, and overall survival) and multivariate analysis.

Main Results

  • WHO II NPC subtype patients exhibited significantly worse survival outcomes than WHO III subtype patients in both cohorts.
  • Specific findings include poorer locoregional relapse-free survival, distant metastasis-free survival, disease-free survival, and overall survival for WHO II subtype in the XM-NPC cohort.
  • The SEER-NPC cohort showed worse NPC-specific survival and overall survival for the WHO II subtype.
  • Multivariate analysis confirmed histology as an independent prognostic factor for NPC outcomes.

Conclusions

  • Histological subtype is a significant prognostic factor in nasopharyngeal carcinoma.
  • Substantial survival disparities exist between WHO II and WHO III NPC subtypes.
  • Findings highlight the importance of considering histological variations for improved NPC patient management and outcomes.

Keywords: